Arcturus Therapeutics
ARCT
ARCT
11 hedge funds and large institutions have $31.6M invested in Arcturus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SC
1
Sophrosyne Capital
New York
|
$2.09M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$5.39M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$263K |
| 4 |
EEG
4
E.E. Geduld
|
$180K |
| 5 |
RFC
5
Russell Frank Company
Seattle,
Washington
|
$106K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
| $12.4M | 676,735 | – | – |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $10.6M | 587,000 | – | – |
|
|
3
JPMorgan Chase & Co
New York
| $5.39M | 298,484 | +58,484 | +24% |
|
|
SC
4
Sophrosyne Capital
New York
| $2.09M | 115,750 | +115,750 | New |
|
|
TMC
5
Trellus Management Company
Delray Beach,
Florida
| $496K | 27,500 | -12,500 | -31% |
|
|
6
Acadian Asset Management
Boston,
Massachusetts
| $263K | 14,529 | +14,529 | New |
|
|
EEG
7
E.E. Geduld
| $180K | 10,000 | +10,000 | New |
|
|
RFC
8
Russell Frank Company
Seattle,
Washington
| $106K | 5,739 | +5,739 | New |
|
|
MP
9
Manifold Partners
San Francisco,
California
| $35K | 1,900 | +1,900 | New |
|
|
PCM
10
Prelude Capital Management
New York
| $25K | 1,400 | +1,400 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $4K | 228 | +228 | New |
|
|
ACPU
12
Arrowgrass Capital Partners (US)
Dover,
Delaware
| – | – | -184,041 | Closed |
|
|
U
13
UBS
Zurich,
Switzerland
| – | – | -405 | Closed |
|